leisure time -WSS

leisure time

author：explore 2025-08-12 11:33:43 - browse：325

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Seattle police shoot person suspected in downtown stabbing

hotspot

WSS

India sets sights on home

How dance can help health care workers heal from trauma

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

New warning issued for rebooking air travel after delays, cancellations

Ebola public health emergency is over, WHO declares

How dance can help health care workers heal from trauma

hotspot

leisure time

Wikipedia

At least 13 dead in Texas as scorching temps continue

Ebola public health emergency is over, WHO declares

Sports medicine is finally prioritizing gender equality

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Peter Hotez and the public health issue of online harassment

Liquid biopsy for lung cancer is launched by Delfi

Anesthesiologist group: stop taking Ozempic before surgery

FDA rejects Alnylam's heart disease treatment over insufficient data

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why the Crimean Bridge is key to Russia's war in Ukraine

focus

Chemotherapy drug shortage eases slightly but still widespread

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Analysis of telehealth claims data suggest service duplication

Bristol 'take

AI can decode, harness the power of the humane immune system

When women are denied an abortion, their children fare worse than peers

focus

hotspot

hotspot

knowledge